Founded in New York City, Bristol-Myers Squibb Company is a leading American pharmaceutical organization dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company's core mission is to transform patients' lives through science, with a vision to be the world's leading biopharma company. Bristol-Myers Squibb offers a range of biopharmaceutical products targeting hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. Key products include Eliquis for stroke/systemic embolism reduction and Opdivo for various anti-cancer indications.

Notable affiliated individuals include key scientists and executives who have driven the company's research and development efforts. The company has received significant investment from major stakeholders in the pharmaceutical industry. Bristol-Myers Squibb's key achievements include the successful development and commercialization of groundbreaking therapies like Eliquis and Opdivo, which have had a substantial impact on patient care globally. The company continues to be a pivotal player in the biopharmaceutical sector, advancing medical research and improving health outcomes worldwide.